CN101934025B - 一种用于清热解毒的中药 - Google Patents
一种用于清热解毒的中药 Download PDFInfo
- Publication number
- CN101934025B CN101934025B CN2010102657804A CN201010265780A CN101934025B CN 101934025 B CN101934025 B CN 101934025B CN 2010102657804 A CN2010102657804 A CN 2010102657804A CN 201010265780 A CN201010265780 A CN 201010265780A CN 101934025 B CN101934025 B CN 101934025B
- Authority
- CN
- China
- Prior art keywords
- heat
- gram
- chinese medicine
- traditional chinese
- radix
- Prior art date
Links
- 239000003814 drugs Substances 0.000 title claims abstract description 35
- 239000000463 materials Substances 0.000 title abstract description 3
- 230000002588 toxic Effects 0.000 title abstract 3
- 231100000331 toxic Toxicity 0.000 title abstract 3
- 231100000614 Poisons Toxicity 0.000 claims description 34
- 239000003440 toxic substances Substances 0.000 claims description 26
- 239000002994 raw materials Substances 0.000 claims description 7
- 230000001717 pathogenic Effects 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 12
- 201000011510 cancer Diseases 0.000 abstract description 9
- 201000010874 syndrome Diseases 0.000 abstract description 7
- 208000006641 Skin Diseases Diseases 0.000 abstract description 5
- 238000009825 accumulation Methods 0.000 abstract description 2
- 235000008216 herbs Nutrition 0.000 abstract description 2
- 230000002045 lasting Effects 0.000 abstract description 2
- 244000052769 pathogens Species 0.000 abstract description 2
- 235000004415 Burchellia bubalina Nutrition 0.000 abstract 1
- 240000008537 Burchellia bubalina Species 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 210000004369 Blood Anatomy 0.000 description 23
- 239000008280 blood Substances 0.000 description 23
- 210000000582 Semen Anatomy 0.000 description 22
- 230000001737 promoting Effects 0.000 description 19
- 230000017531 blood circulation Effects 0.000 description 17
- 241000628997 Flos Species 0.000 description 15
- 206010028980 Neoplasm Diseases 0.000 description 11
- 210000004915 Pus Anatomy 0.000 description 11
- 210000003491 Skin Anatomy 0.000 description 9
- 241000209020 Cornus Species 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 239000002574 poisons Substances 0.000 description 8
- 230000025627 positive regulation of urine volume Effects 0.000 description 8
- 230000001047 pyretic Effects 0.000 description 8
- 230000002522 swelling Effects 0.000 description 8
- 230000001988 toxicity Effects 0.000 description 8
- 231100000419 toxicity Toxicity 0.000 description 8
- 206010007247 Carbuncle Diseases 0.000 description 7
- 210000004072 Lung Anatomy 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 241001088417 Ammodytes americanus Species 0.000 description 4
- 241000746375 Andrographis Species 0.000 description 4
- 210000001124 Body Fluids Anatomy 0.000 description 4
- 240000000218 Cannabis sativa Species 0.000 description 4
- 241001100935 Ilex purpurea Species 0.000 description 4
- 235000003366 Ilex purpurea Nutrition 0.000 description 4
- 240000004753 Ixora coccinea Species 0.000 description 4
- 241000283956 Manis Species 0.000 description 4
- 241000219098 Parthenocissus Species 0.000 description 4
- 241000219099 Parthenocissus quinquefolia Species 0.000 description 4
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 description 4
- 235000001238 Solanum aculeastrum Nutrition 0.000 description 4
- 241000047359 Solanum aculeastrum Species 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 201000010099 diseases Diseases 0.000 description 4
- 229940079593 drugs Drugs 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 230000001939 inductive effects Effects 0.000 description 4
- 230000004936 stimulating Effects 0.000 description 4
- 206010000496 Acne Diseases 0.000 description 3
- 241001334808 Commelina paludosa Species 0.000 description 3
- 241000668709 Dipterocarpus costatus Species 0.000 description 3
- 241000321541 Leptolegnia sp. Species 0.000 description 3
- 210000004080 Milk Anatomy 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 241000545442 Radix Species 0.000 description 3
- 239000010231 banlangen Substances 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000002175 menstrual Effects 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 235000006463 Brassica alba Nutrition 0.000 description 2
- 244000140786 Brassica hirta Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010048768 Dermatosis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010013781 Dry mouth Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000005679 Eczema Diseases 0.000 description 2
- 239000007815 EtOH Substances 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 206010024324 Leukaemias Diseases 0.000 description 2
- 241001608711 Melo Species 0.000 description 2
- 235000009815 Momordica Nutrition 0.000 description 2
- 241000218984 Momordica Species 0.000 description 2
- 210000001331 Nose Anatomy 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 240000005373 Panax quinquefolius Species 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 240000001816 Prunella vulgaris Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241001529553 Scoparia <angiosperm> Species 0.000 description 2
- 210000000952 Spleen Anatomy 0.000 description 2
- 210000002700 Urine Anatomy 0.000 description 2
- 241000934136 Verruca Species 0.000 description 2
- 208000000260 Warts Diseases 0.000 description 2
- 230000003110 anti-inflammatory Effects 0.000 description 2
- 201000004624 dermatitis Diseases 0.000 description 2
- 231100001003 eczema Toxicity 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000003419 expectorant Effects 0.000 description 2
- 239000003172 expectorant agents Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000000414 obstructive Effects 0.000 description 2
- 210000000056 organs Anatomy 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 201000010153 skin papilloma Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000036269 ulceration Effects 0.000 description 2
- 241000722941 Achillea Species 0.000 description 1
- 241000605447 Anemarrhena Species 0.000 description 1
- 208000006673 Asthma Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 210000000988 Bone and Bones Anatomy 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 241000555682 Forsythia x intermedia Species 0.000 description 1
- 206010017758 Gastric cancer Diseases 0.000 description 1
- 241000533849 Gleditsia Species 0.000 description 1
- 241000208818 Helianthus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 210000000936 Intestines Anatomy 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 210000003734 Kidney Anatomy 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 210000003205 Muscles Anatomy 0.000 description 1
- 206010025310 Other lymphomas Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 206010037844 Rash Diseases 0.000 description 1
- 206010040943 Skin ulcer Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 280000967897 Sting companies 0.000 description 1
- 210000002784 Stomach Anatomy 0.000 description 1
- 210000002435 Tendons Anatomy 0.000 description 1
- 206010068760 Ulcers Diseases 0.000 description 1
- 210000004291 Uterus Anatomy 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 238000004458 analytical methods Methods 0.000 description 1
- 230000000507 anthelmentic Effects 0.000 description 1
- 230000001396 anti-anti-diuretic Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 201000009030 carcinoma Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000001882 diuretic Effects 0.000 description 1
- 239000002934 diuretics Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering processes Methods 0.000 description 1
- 230000003203 everyday Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000001815 facial Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000004054 inflammatory processes Effects 0.000 description 1
- 230000001983 lactogenic Effects 0.000 description 1
- 230000004301 light adaptation Effects 0.000 description 1
- 239000007788 liquids Substances 0.000 description 1
- 230000003211 malignant Effects 0.000 description 1
- 230000001473 noxious Effects 0.000 description 1
- 230000021603 oncosis Effects 0.000 description 1
- 235000020825 overweight Nutrition 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000843 powders Substances 0.000 description 1
- 238000002360 preparation methods Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000003014 reinforcing Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 239000003053 toxins Substances 0.000 description 1
- 231100000397 ulcers Toxicity 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Abstract
本发明公开了一种用于清热解毒的中药，该中药是由紫参、水牛角、牡丹皮等数十味中草药经粉碎、研磨制备而成。本发明药物的有益效果是适应面广，可用于由风邪、热邪、火邪引起各种热证患者，尤其是对于各种热毒蕴积的肿瘤病人。经数十名肿瘤病人的治疗应用表明，本发明药物不仅起效快，而且疗效持久稳定。本发明药物在治疗皮肤病的应用中疗效更加明显。
Description
一种用于清热解毒的中药
技术领域
[0001 ] 本发明涉及一种用于清热解毒的中药。
背景技术
[0002] 中医认为热证是人体感受阳热之邪，如风邪、热邪、火邪等，或阳盛阴虚、脏腑阳气亢盛和阴液亏损、机能活动亢进所表现的证候。临床上许多肿瘤和不少顽固的皮肤疾患都是很典型的热证表现。
[0003] 中医认为热毒是恶性肿瘤的主要病因，是由热、火、痰、瘀等所致，造成机体脏腑功能失调，阴阳失衡。热邪侵犯或其它病邪郁久化热，热灼津液，炼液为痰，痰湿不化阻碍气机运行，气滞则血瘀，瘀久化火，火毒内蕴，郁结成块，积聚于机体某部而成癌肿。恶性肿瘤患者常有邪热、瘀毒蕴结体内，临床上表现为邪热壅盛，特别是那些晚期肿瘤患者，常伴有局部肿块灼热、疼痛、发热、五心烦热、口渴、尿赤、便秘或便溏泄泻，舌苔黄腻等热性。恶性肿瘤癌块溃破形成的“恶疮”也为邪毒留着郁久化热所致。
[0004] 另外，中医还认为，凡由热邪引起的皮肤疮疡、红肿发痒之证也皆因心火炽盛，复感风热之邪，蕴结肌肤，热邪与血相搏而致皮肤疮疡。在证候变化多端之中，脏腑气血失调是其内因，外邪致病是条件，病之初常为风热之邪，侵犯肌肤，证属风热犯肤；进而热毒人营，蕴于血络，而见热毒炽盛之证，后期热毒伤阴，肌肤失养可见热盛伤阴证。
[0005] 目前有关治疗皮肤疾患和治疗各种肿瘤的药物并不少见，其中也有相当一大部分还是基于清热解毒原理设计的，但是从目前的使用状况看，这类药物的适应范围和疗效作用还有待于进一步提高。
发明内容
[0006] 本发明要解决的技术问题是提供一种用于清热解毒的中药，该中药适用面广、疗效确切稳定。
[0007] 本发明药物的原料组成及重量份配比是：
紫参40-60份一枝蒿10-20份蒲公英40-60份白芷10-20份地黄10-20份板兰根40-60份贯众10-20份王不留行10-20份桃仁10-20份金银花10-20份芙蓉叶10-20份
水牛角40-60份穿山甲10-20份毛冬青10-20份桔梗10-20份羊蹄10-20份黄芪20-40份贝母10-20份木鳖子10-20份甜瓜子40-60份夏枯草10-20份乌桕根皮10-20份
牡丹皮10-30份漏芦10-20份四叶参10-20份白蔹10-20份红芪10-20份紫草10-20份连翘10-20份白芥子20-40份红花10-20份四季青10-20份爬山虎10-20份败毒草10-20份野颠茄20-40份苏方木10-20份鹿茸10-20份赤小豆40-60份
穿心莲10-20份莲子10-20份茵陈10-20份芫花20-40份大苞鸭跖草10-20份
乌蔹毒10-20份龙葵花10-20份慈姑10-20份知母10-20份金荞麦10-20份在上述原料组分中还可以再加入： 喜树果40-60份了哥王10-20份野菊花10-20份三尖杉20-40份皂角刺40-60份败酱草10-20份以下是上述本发明药物各种原料的药性： 紫参：清热解毒，活血理气止痛。 水牛角：清热、凉血、解毒。 牡丹皮：清热凉血；活血散瘀。 了哥王：清热解毒，消肿散结，止痛。 一枝蒿：祛风解表；健胃消积；活血散瘀。 穿山甲：活血散结；通经下乳；消痈溃坚。 漏芦：清热解毒，消痈，下乳，舒筋通脉。 蒲公英：清热解毒，消肿散结。 毛冬青：活血通脉，消肿止痛，清热解毒。 四叶参：消肿，解毒，排脓，祛痰，催乳。 白芷：祛风湿，活血排脓，生肌止痛。 桔梗：宣肺、祛痰、利咽、排脓。 白蔹：清热解毒，消痈散结。 地黄：清热凉血；生津润燥。 羊蹄：清热解毒，止血，通便。 红芪：补气固表，利尿托毒，排脓，敛疮生肌。 板兰根：清热，解毒，凉血，利咽。 黄芪：益气固表、敛汗固脱、托疮生肌、利水消肿。 紫草：凉血，活血，解毒透疹。
金荞麦：清热解毒；活血消痈；祛风除湿疮毒；蛇虫咬伤
贯众：清热解毒，凉血止血，杀虫。
贝母：清热润肺，化痰止咳。
连翘：清热解毒，散结消肿。
喜树果：抗癌，散结，破血化瘀。
王不留行：活血通经，下乳消痈，利尿通淋。
木鳖子：消肿散结，祛毒。
白芥子：温肺豁痰利气，散结通络止痛。
桃仁：活血祛瘀，润肠通便，止咳平喘。
甜瓜子：化痰，排脓，散结消瘀，清肺润肠。
红花：活血通经、散瘀止痛。[0058] 金银花：清热解毒。
[0059] 夏枯草：清肝、散结、利尿。
[0060] 野菊花：清热解毒，消肿。
[0061] 三尖杉：驱虫，消积。
[0062] 四季青：清热解毒，活血止血。
[0063] 芙蓉叶：清肺凉血，消肿排脓。
[0064] 乌桕根皮：清热利湿，拔毒消肿。
[0065] 皂角刺：消肿托毒，排脓，杀虫。
[0066] 爬山虎：活血解毒，用于风湿关节痛。
[0067] 败毒草：解毒，燥湿止痒。
[0068] 乌蔹莓：清热解毒，活血散瘀，利尿。
[0069] 穿心莲：清热解毒、消炎、消肿止痛。
[0070] 败酱草：清热解毒，消痈排脓，活血行瘀。
[0071] 野颠茄：散瘀消肿，止痛拔毒。
[0072] 龙葵花：清热解毒，利水消肿。
[0073] 莲子：清心醒脾，补脾止泻，滋补元气。
[0074] 苏方木：活血化瘀，消肿止痛。
[0075] 慈姑：生津润肺，补中益气，败火消炎。
[0076] 茵陈：清湿热，退黄疸。
[0077] 鹿茸：补精髓，助肾阳，强筋健骨。
[0078] 知母：清热泻火，生津润燥。
[0079] 芫花：泻水逐饮，解毒杀虫。
[0080] 赤小豆：利水消种，解毒排脓。
[0081] 大苞甲跖草：利水消肿，清热解毒，凉血止血。
[0082] 本发明药物具有清热解毒、消散痈肿等多重药理作用，适用于治疗多种恶性肿瘤， 包括肺癌、胃癌、肝癌、乳线癌、子宫癌、膀胱癌、白血病、恶性淋巴瘤等。尤其适合于各种肿瘤的早、中期，表现为热毒蕴积，有口干、便结、尿黄、舌红、脉数等症状者服用。
[0083] 另外，本发明药物对于由热毒引起的各种皮肤病，如痤疮、扁平疣、酒精鼻、湿疹等具有极好的疗效。
[0084] 本发明药物的制备及服用方法是按组方比例选取药物原料，经清洗，干燥后，粉碎至60目，将1000克药物粉末分成60份，每日早、晚各服一份，30天为一疗程。
[0085] 本发明药物的有益效果是适应面广，可用于由风邪、热邪、火邪引起各种热证患者，尤其是对于各种热毒蕴积的肿瘤病人。经数十名肿瘤病人的治疗应用表明，本发明药物不仅起效快，而且疗效持久稳定。本发明药物在治疗皮肤病的应用中疗效更加明显。
具体实施例
[0086] 例 1
[0087] 本发明药物的原料组成及重量份配比是：
[0088] 紫参60克水牛角40克牡丹皮10克用于年迈体虚的肿瘤病患者。
0089]
0090]
0091]
0092]
0093]
0094]
0095]
0096]
0097]
0098]
0099]
0100] 0101] 0102]
0103]
0104]
一枝蒿10克蒲公英40克白芷10克地黄20克板兰根40克贯众20克王不留行10克桃仁10克金银花20克芙蓉叶10克败毒草20克野颠茄20克苏方木10克鹿茸10克赤小豆50份
穿山甲15克毛冬青10克桔梗20克羊蹄10克黄芪30克贝母10克木鳖子20克甜瓜子40克夏枯草15克乌桕根皮10克乌蔹毒10克龙葵花10克慈姑10克知母20克金荞麦20克
漏芦20克四叶参20克白蔹15克红芪10克紫草20克连翘10克白芥子20克红花10克四季青10克爬山虎10克穿心莲15克莲子20克茵陈10克芫花20克大苞鸭跖草20克
本例药物可用于治疗由热毒引起的各种皮肤病，具有快速、稳定的治疗效果，也可
0105] 例2 0106] 本发明药物的原料组成及重量份配比是： 0107] 紫参50克 水牛角50克 牡丹皮20克0108] 了哥王20克 一枝蒿20克 穿山甲20克0109] 漏芦20克 蒲公英50克 毛冬青20克0110] 四叶参20克 白芷20克 桔梗20克0111] 白蔹20克 地黄20克 羊蹄20克0112] 红芪50克 板兰根50克 黄芪30克0113] 紫草20克 金荞麦20克 贯众20克0114] 贝母0克 连翘20克 喜树果50克0115] 王不留行20克 木鳖子20克 白芥子30克0116] 桃仁20克 甜瓜子50克 红花20克0117] 金银花20克 夏枯草20克 野菊花20克0118] 三尖杉30克 四季青20克 芙蓉叶20克0119] 乌桕根20克 皂角刺50克 爬山虎20克0120] 败毒草20克 乌蔹毒20克 穿心莲20克0121] 败酱20克 野颠茄30克 大苞鸭跖草200122] 龙葵花20克 莲子20克 苏方木20克0123] 慈姑20克 茵陈20克 ） 竜茸10克0124] 知母20克 芫花30克赤小豆50克 0125] 本例药物适用于各种肿瘤病患者的临床治疗。 0126] 例3[0127] 本发明药物的疗效分析：
[0128] 1、有关肿瘤病的治疗：
[0129] 近两年多的时间里，本发明药物共用于31例多类肿瘤病患者的治疗，其中消化系统肿瘤11人，呼吸系统肿瘤5人，皮肤肿瘤9人，面部肿瘤5人，白血病1人。治疗前这些病人的共同症状都是热毒过重，或积或瘀，表现为发烧、烦热，口干舌燥，大便秘结，病灶流浓、 溃烂、患面扩大迅速。在服用了本发明药物两周之后，上述症状绝大多数都得到了明显的控制和缓解，绝大多数患者出现了体温下降，体能上升，在连续服用三个月后，患者的病灶都有收敛，部分患者甚至完全愈合。
[0130] 2、有关皮肤病的治疗：
[0131] 本发明药物在用于皮肤病的治疗中收到了显著的疗效，疗效最感突出的就是治疗痤疮、青春痘、扁平疣、酒精鼻、湿疹等，治疗50例，完全痊愈者高达42例，明显好转者12 例，即治愈率为82 %，总有效率为98 %。
Claims (2)
1. 一种用于清热解毒的中药，该中药的原料组成及重量份配比是：紫参40-60份 水牛角40-60份 牡丹皮10-30份一枝蒿10-20份 穿山甲10-20份 漏芦10-20份蒲公英40-60份 毛冬青10-20份 四叶参10-20份白芷10-20份 桔梗10-20份 白蔹10-20份地黄10-20份 羊蹄10-20份 红芪10-20份板兰根40-60份 黄芪20-40份 紫草10-20份贯众10-20份 贝母10-20份 连翘10-20份王不留行10-20份 木鳖子10-20份 白芥子20-40份桃仁10-20份 甜瓜子40-60份 红花10-20份金银花10-20份 夏枯草10-20份 四季青10-20份芙蓉叶10-20份 乌桕根皮10-20份 爬山虎10-20份败毒草10-20份 乌蔹毒10-20份 穿心莲10-20份野颠茄20-40份 龙葵花10-20份 莲子10-20份苏方木10-20份 慈姑10-20份 茵陈10-20份鹿茸10-20份 知母10-20份 芫花20-40份赤小豆40-60份 金荞麦10-20份 大苞鸭跖草10-20份。
2. 一种用于清热解毒的中药，该中药的原料组成及· 【量份配比是：紫参40-60份 水牛角40-60份 牡丹皮10-30份一枝蒿10-20份 穿山甲10-20份 漏芦10-20份蒲公英40-60份白芷10-20份地黄10-20份板兰根40-60份贯众10-20份王不留行10-20份桃仁10-20份金银花10-20份芙蓉叶10-20份败毒草10-20份野颠茄20-40份苏方木10-20份鹿茸10-20份赤小豆40-60份喜树果40-60份三尖杉20-40份毛冬青10-20份桔梗10-20份羊蹄10-20份黄芪20-40份贝母10-20份木鳖子10-20份甜瓜子40-60份夏枯草10-20份乌桕根皮10-20份乌蔹毒10-20份龙葵花10-20份慈姑10-20份知母10-20份金荞麦10-20份了哥王10-20份皂角刺40-60份四叶参10-20份白蔹10-20份红芪10-20份紫草10-20份连翘10-20份白芥子20-40份红花10-20份四季青10-20份爬山虎10-20份穿心莲10-20份莲子10-20份茵陈10-20份芫花20-40份大苞鸭跖草10-20份野菊花10-20份败酱草10-20份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102657804A CN101934025B (zh) | 2010-08-18 | 2010-08-18 | 一种用于清热解毒的中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102657804A CN101934025B (zh) | 2010-08-18 | 2010-08-18 | 一种用于清热解毒的中药 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101934025A CN101934025A (zh) | 2011-01-05 |
| CN101934025B true CN101934025B (zh) | 2011-11-30 |
Family
ID=43387746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102657804A CN101934025B (zh) | 2010-08-18 | 2010-08-18 | 一种用于清热解毒的中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101934025B (zh) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102302621A (zh) * | 2011-08-19 | 2012-01-04 | 南充市创科生物科技有限责任公司 | 一种治疗肝癌的中草药药物 |
| CN102580053B (zh) * | 2012-03-29 | 2014-02-19 | 翟西菊 | 一种预防及治疗癌症的中药 |
| CN103141831A (zh) * | 2013-01-17 | 2013-06-12 | 延边大学 | 一种具有肝保护功能的朝医保健食品组合物及其制备方法和用途 |
| CN103316203B (zh) * | 2013-07-13 | 2014-08-20 | 瑞安市视尚光学眼镜科技有限公司 | 一种用于治疗扭伤的外用中药 |
| CN103341144B (zh) * | 2013-07-13 | 2014-12-10 | 解祥军 | 一种治疗便秘的中药 |
| CN105726975A (zh) * | 2014-05-13 | 2016-07-06 | 张春元 | 一种治疗卫表不固型荨麻疹的中药制剂 |
| CN104146309B (zh) * | 2014-08-30 | 2015-11-11 | 余丽珍 | 一种香蕉果汁饮品 |
| CN106138144A (zh) * | 2015-02-17 | 2016-11-23 | 钟森 | 漏芦的新用途 |
| CN106109791A (zh) * | 2016-08-26 | 2016-11-16 | 吕晶晶 | 一种治疗肝癌的中药组合物及其制备方法 |
| CN106491937A (zh) * | 2016-12-25 | 2017-03-15 | 闫大伟 | 一种治疗大肠湿热证的中药 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1265901A (zh) * | 2000-01-26 | 2000-09-13 | 徐忠廷 | 一种抗癌中药丸剂 |
| CN1324632A (zh) * | 2000-05-18 | 2001-12-05 | 董丽 | 一种治疗肿瘤的中药制剂 |
| CN101011559A (zh) * | 2007-02-01 | 2007-08-08 | 南中兴 | 治疗恶性肿瘤的中药制剂及其制备方法 |
| CN101020031A (zh) * | 2007-03-08 | 2007-08-22 | 王俊川 | 一种治疗痤疮的中草药制剂 |
-
2010
- 2010-08-18 CN CN2010102657804A patent/CN101934025B/zh not_active IP Right Cessation
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1265901A (zh) * | 2000-01-26 | 2000-09-13 | 徐忠廷 | 一种抗癌中药丸剂 |
| CN1324632A (zh) * | 2000-05-18 | 2001-12-05 | 董丽 | 一种治疗肿瘤的中药制剂 |
| CN101011559A (zh) * | 2007-02-01 | 2007-08-08 | 南中兴 | 治疗恶性肿瘤的中药制剂及其制备方法 |
| CN101020031A (zh) * | 2007-03-08 | 2007-08-22 | 王俊川 | 一种治疗痤疮的中草药制剂 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101934025A (zh) | 2011-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101884770B (zh) | 治疗尿石症的中药制剂及其制备方法 | |
| CN101564521B (zh) | 一种治疗乳腺增生的外用膏药 | |
| CN101791377B (zh) | 一种用于宫颈炎、宫颈肥大术后康复的中药制剂 | |
| CN103055130B (zh) | 治疗慢性咽炎的中药组合物及其制备方法 | |
| CN100551422C (zh) | 一种治疗椎间盘突出的内服药物 | |
| CN101066303B (zh) | 治疗脑血栓、脑血管硬化和中风偏瘫的药物及其制备方法 | |
| CN1315525C (zh) | 一种治疗乳房疾病的中药及其制作工艺 | |
| CN101954062B (zh) | 一种治疗慢性咽炎的药物 | |
| CN100367985C (zh) | 一种消骨镇痛的中成药 | |
| CN101874867B (zh) | 治疗银屑病中药剂 | |
| CN103272199B (zh) | 一种治疗冻伤的药物 | |
| CN103893727A (zh) | 一种止痛活血舒筋贴膏及其制备方法 | |
| CN101954011B (zh) | 一种治疗尿道炎的中药制剂 | |
| CN100364589C (zh) | 一种治疗银屑病的中药 | |
| CN103341145B (zh) | 一种治疗银屑病的中药及其制备方法 | |
| CN101862428B (zh) | 一种治疗前列腺增生的中药 | |
| CN105012392A (zh) | 一种用于治疗鼻炎的中药组合物及其制备方法 | |
| CN102846803B (zh) | 一种治疗脚气的外用药物 | |
| CN105535715A (zh) | 治疗湿热内蕴型湿疹的中药外洗液 | |
| CN102091295A (zh) | 一种治疗股骨头坏死的中药组合物及其制备方法 | |
| CN103751562B (zh) | 一种治疗结石的中药 | |
| CN102631513B (zh) | 一种用于化淤散结消肿的药贴及其制备方法 | |
| CN101361894A (zh) | 治疗乳腺炎症的药物 | |
| CN102631413B (zh) | 一种治疗痤疮的中药组合物 | |
| CN101327298B (zh) | 一种治疗瘙痒性皮肤病的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DD01 | Delivery of document by public notice |
Addressee: Zhao Quanhui Document name: Notification of Acceptance of Patent Application |
|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111130 Termination date: 20130818 |